About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of Aripiprazole in Patients With Bipolar I Disorder

Study of Aripiprazole in Patients With Bipolar I Disorder

NCT00257972·90 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

With

Otsuka America Pharmaceutical

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Clinical diagnosis of bipolar I disorder, manic or mixed episode

You may not be if

First manic or mixed episode
Allergic, intolerant, or unresponsive to lithium and valproate or to aripiprazole
Participation in a previous clinical trial within the past month or ever participated in a trial with aripiprazole

The record

StatusCompleted

PhasePhase 3

Taking part400

StartedOct 2004

UpdatedNov 8, 2013

Conditions

Bipolar Disorder

Where90

Local Institution
Little Rock, Arkansas, United States
Local Institution
Riverside, California, United States
Local Institution
Deerfield Beach, Florida, United States